{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:13:30Z","timestamp":1773944010183,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ejim.2008.04.003","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T09:51:47Z","timestamp":1213177907000},"page":"53-57","source":"Crossref","is-referenced-by-count":16,"title":["The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication"],"prefix":"10.1016","volume":"20","author":[{"given":"Murat","family":"Akyildiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Akay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Musoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muge","family":"Tuncyurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2008.04.003_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/bmj.323.7318.920","article-title":"ABC of the upper gastrointestinal tract: epidemiology and diagnosis of Helicobacter pylori infection","volume":"323","author":"Logan","year":"2001","journal-title":"BMJ"},{"issue":"suppl","key":"10.1016\/j.ejim.2008.04.003_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00365529309098333","article-title":"Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer","volume":"196","author":"Sipponen","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2008.04.003_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0140-6736(93)91404-A","article-title":"Healing gastric MALT lymphoma by eradication of H. pylori?","volume":"342","author":"Stolte","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2008.04.003_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection\u2014 The Maastricht 2\u20132000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000094040","article-title":"Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy","volume":"73","author":"Gu","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.ejim.2008.04.003_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection \u2014 The Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2008.04.003_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11908-005-0071-4","article-title":"Update on therapeutic options for Helicobacter pylori-related diseases","volume":"7","author":"Megraud","year":"2005","journal-title":"Curr Infect Dis Rep"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2008.04.003_bib8","first-page":"A5","article-title":"Turkiye'de H. pylori eradikasyonunda PPI, klaritromisin ve amoksisilin rejimlerinin etkinligi: bir meta-analiz","volume":"15","author":"Kadayifci","year":"2004","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.ejim.2008.04.003_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.1999.00555.x","article-title":"A systematic review of Helicobacter pylori eradication therapy\u2014the impact of antimicrobial resistance on eradication rates","volume":"13","author":"Houben","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2008.04.003_bib10","first-page":"A12","article-title":"Ranitidine bismuth citrate can overcome in vitro antibiotic resistance in Helicobacter pylori","volume":"41","author":"Midolo","year":"1997","journal-title":"Gut"},{"issue":"suppl","key":"10.1016\/j.ejim.2008.04.003_bib11","first-page":"A1057","article-title":"Ranitidine bismuth citrate enhances clarithromycin activity against clinical isolates of H. pylori","volume":"112","author":"Osato","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2008.04.003_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1523-5378.2000.00034.x","article-title":"Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo","volume":"5","author":"Megraud","year":"2000","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2008.04.003_bib13","first-page":"448","article-title":"The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate\u2014vs. omeprazole-based one-week triple therapies in H. pylori eradication\u2014a randomised controlled trial","volume":"114","author":"Bago","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ejim.2008.04.003_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2036.1999.00462.x","article-title":"Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy","volume":"1","author":"Rinaldi","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib15","first-page":"1006","article-title":"Efficacy and tolerability of ranitidine bismuth citrate plus amoxicillin and clarithromycin as first-or second-line therapy to cure Helicobacter pylori infection","volume":"49","author":"Tursi","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2008.04.003_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1365-2036.1999.00615.x","article-title":"Seven-day \u2018rescue\u2019 therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole","volume":"13","author":"Gisbert","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1440-1746.2005.03801.x","article-title":"Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients","volume":"20","author":"Koksal","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2008.04.003_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2036.2003.01653.x","article-title":"Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori","volume":"18","author":"Chi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib19","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AAC.44.11.3203-3205.2000","article-title":"Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori","volume":"44","author":"Kwon","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejim.2008.04.003_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000007159","article-title":"Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori","volume":"45","author":"Iovene","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejim.2008.04.003_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0369-8114(01)00209-7","article-title":"Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole\u2013amoxicillin\u2013clarithromycin therapy","volume":"49","author":"Tankovic","year":"2001","journal-title":"Pathol Biol"},{"key":"10.1016\/j.ejim.2008.04.003_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A metaanalysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2008.04.003_bib23","first-page":"A55","article-title":"Helicobacter pylori\u2019nin klaritromisine duyarliligi azaliyor mu?","volume":"9","author":"Aydin","year":"1998","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.ejim.2008.04.003_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/MCG.0b013e31802e7ee7","article-title":"High Helicobacter pylori resistance rate to clarithromycin in Turkey","volume":"41","author":"Onder","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2008.04.003_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2007.02.018","article-title":"Comparison of one and two-week pantoprazole-based triple therapies in clarithromycin sensitive and resistant cases","volume":"18","author":"Aydin","year":"2007","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.ejim.2008.04.003_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2036.2002.01220.x","article-title":"Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies","volume":"16","author":"Georgopoulos","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2036.1993.tb00076.x","article-title":"Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection-tetracycline, amoxicillin, bismuth","volume":"1","author":"Graham","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1083-4389.2002.00066.x","article-title":"Amoxicillin\/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection","volume":"7","author":"Perri","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2008.04.003_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2004.01910.x","article-title":"High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection","volume":"19","author":"Cammarota","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2008.04.003_bib30","first-page":"A103","article-title":"\u2018Rescue\u2019 therapy including ranitidine bismuth citrate+minocicline+amoxicillin for eradication of Helicobacter pylori infection in previous H.P. treatment failure","volume":"41","author":"Cudia","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2008.04.003_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1365-2036.2000.00833.x","article-title":"Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients","volume":"14","author":"Gomollon","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2008.04.003_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1440-1746.2006.04291.x","article-title":"Combinations containing amoxicillin\u2013clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility","volume":"21","author":"Cheon","year":"2006","journal-title":"J Gastroenterol Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T07:53:23Z","timestamp":1709020403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0953620508001337"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2008.04.003","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}